Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We use our state-of-the-art dedicated workflow for designing focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The procedure entails thorough molecular simulations of the catalytic and allosteric binding pockets, accompanied by ensemble virtual screening that factors in their conformational flexibility. When developing modulators, the structural modifications brought about by reaction intermediates are factored in to optimize activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q9HBD1
UPID:
RC3H2_HUMAN
Alternative names:
Membrane-associated nucleic acid-binding protein; RING finger and CCCH-type zinc finger domain-containing protein 2; RING finger protein 164; RING-type E3 ubiquitin transferase Roquin-2
Alternative UPACC:
Q9HBD1; Q4VXB1; Q5JPD7; Q86ST6; Q8N3D6; Q96F27; Q9H5J2; Q9HBD2; Q9NWN9; Q9NXE1
Background:
Roquin-2, known for its roles as a post-transcriptional repressor and ubiquitin E3 ligase, is pivotal in mRNA degradation and ubiquitination processes. It binds to a conserved stem loop motif in mRNAs, promoting their deadenylation and degradation, crucial for controlling inflammation in macrophages and preventing autoimmunity by repressing ICOS and TNFRSF4 expression in T cells. Additionally, Roquin-2 regulates microRNA homeostasis and enhances DICER-mediated processing, showcasing its multifaceted biological functions.
Therapeutic significance:
Understanding the role of Roquin-2 could open doors to potential therapeutic strategies.